CalciMedica is a privately held, clinical-stage biotechnology company with a platform focused on CRAC channel drug discovery and development for the treatment of acute and severe inflammatory diseases.
Kyverna Therapeutics
7 followers
Strand Therapeutics
3 followers
Nuvalent
2 followers
School District of Philadelphia
5 followers
Watchmaker Genomics
5 followers
DECA
4 followers
iGEM
1 follower
James Madison University
2 followers
Forge Biologics
2 followers
Apogee Therapeutics
2 followers
CG Oncology
2 followers
Leapcure
2 followers